These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25830231)

  • 21. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Glasgow Prognostic Score is an independent prognostic predictor of hepatocellular carcinoma following radical resection.
    Pan QX; Zhang JH; Su ZJ; Wang CR; Ke SY
    Oncol Res Treat; 2014; 37(4):192-7. PubMed ID: 24732643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined measurement of preoperative α-fetoprotein and des-γ-carboxy prothrombin predicts recurrence after curative resection in patients with hepatitis-B-related hepatocellular carcinoma.
    Chon YE; Choi GH; Lee MH; Kim SU; Kim DY; Ahn SH; Kim KS; Choi JS; Han KH; Chon CY; Park JY
    Int J Cancer; 2012 Nov; 131(10):2332-41. PubMed ID: 22362471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
    N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
    Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection.
    Huang JL; Fu YP; Jing CY; Yi Y; Sun J; Gan W; Lu ZF; Zhou J; Fan J; Qiu SJ
    J Surg Oncol; 2018 Mar; 117(4):625-633. PubMed ID: 29165812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anatomical versus non-anatomical resection for hepatocellular carcinoma.
    Marubashi S; Gotoh K; Akita H; Takahashi H; Ito Y; Yano M; Ishikawa O; Sakon M
    Br J Surg; 2015 Jun; 102(7):776-84. PubMed ID: 25847111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic performance of preoperative gadoxetic acid-enhanced MRI in resectable hepatocellular carcinoma.
    Shim JH; Han S; Shin YM; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    J Magn Reson Imaging; 2015 Apr; 41(4):1115-23. PubMed ID: 24841479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent hepatocellular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence.
    Parfitt JR; Marotta P; Alghamdi M; Wall W; Khakhar A; Suskin NG; Quan D; McAllister V; Ghent C; Levstik M; McLean C; Chakrabarti S; Garcia B; Driman DK
    Liver Transpl; 2007 Apr; 13(4):543-51. PubMed ID: 17394152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic nomograms for prediction of recurrence and survival after curative liver resection for hepatocellular carcinoma.
    Shim JH; Jun MJ; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC
    Ann Surg; 2015 May; 261(5):939-46. PubMed ID: 24950276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of resection of giant hepatocellular carcinoma in a tertiary institution: does size matter?
    Thng Y; Tan JK; Shridhar IG; Chang SK; Madhavan K; Kow AW
    HPB (Oxford); 2015 Nov; 17(11):988-93. PubMed ID: 26334002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic resection for hepatocellular carcinoma in elderly patients.
    Yeh CN; Lee WC; Jeng LB; Chen MF
    Hepatogastroenterology; 2004; 51(55):219-23. PubMed ID: 15011868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forns index predicts recurrence and death in patients with hepatitis B-related hepatocellular carcinoma after curative resection.
    Choi WM; Lee JH; Ahn H; Cho H; Cho YY; Lee M; Yoo JJ; Cho Y; Lee DH; Lee YB; Cho EJ; Yu SJ; Yi NJ; Lee KW; Kim YJ; Yoon JH; Suh KS; Kim CY; Lee HS
    Liver Int; 2015 Aug; 35(8):1992-2000. PubMed ID: 25556714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
    Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ; Wang ST; Chow NH; Chang TT; Lin PW; Tu DG
    Cancer; 2002 Jul; 95(1):112-8. PubMed ID: 12115324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum WFA+ -M2BP levels as a prognostic factor in patients with early hepatocellular carcinoma undergoing curative resection.
    Toyoda H; Kumada T; Tada T; Kaneoka Y; Maeda A; Korenaga M; Mizokami M; Narimatsu H
    Liver Int; 2016 Feb; 36(2):293-301. PubMed ID: 26134114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of prognostic scores after liver resection in hepatocellular carcinoma: the MSKCC, SLICER and SSCLIP scores.
    Chan EE; Chow PK
    Jpn J Clin Oncol; 2017 Apr; 47(4):287-293. PubMed ID: 27980082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for hepatocellular carcinoma in Singapore.
    Wai CT; Lee YM; Wang SC; Da Costa M; Isaac J; Wee A; Lim SG
    Singapore Med J; 2006 Jul; 47(7):584-7. PubMed ID: 16810428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.
    Chang PE; Ong WC; Lui HF; Tan CK
    J Gastroenterol; 2008; 43(11):881-8. PubMed ID: 19012042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria.
    Lim KC; Wang VW; Siddiqui FJ; Shi L; Chan ES; Oh HC; Tan SB; Chow PK
    Hepatology; 2015 Jan; 61(1):227-37. PubMed ID: 24638991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.